Abstract
Serious side effects may result from the concurrent administration of the usual dosage of carbamazepine and dextropropoxyphene. Three cases are reported and the mechanisms and implications discussed.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bertilsson L. Clinical pharmacokinetics of carbamazepine. Clin Pharmacokinet. 1978 Mar-Apr;3(2):128–143. doi: 10.2165/00003088-197803020-00003. [DOI] [PubMed] [Google Scholar]
- Dam M., Kristensen C. B., Hansen B. S., Christiansen J. Interaction between carbamazepine and propoxyphene in man. Acta Neurol Scand. 1977 Dec;56(6):603–607. doi: 10.1111/j.1600-0404.1977.tb01465.x. [DOI] [PubMed] [Google Scholar]
- Gold E. Serologic and virus-isolation studies of patients with varicella or herpes-zoster infection. N Engl J Med. 1966 Jan 27;274(4):181–185. doi: 10.1056/NEJM196601272740403. [DOI] [PubMed] [Google Scholar]
- Hansen B. S., Dam M., Brandt J., Hvidberg E. F., Angelo H., Christensen J. M., Lous P. Influence of dextropropoxyphene on steady state serum levels and protein binding of three anti-epileptic drugs in man. Acta Neurol Scand. 1980 Jun;61(6):357–367. doi: 10.1111/j.1600-0404.1980.tb01505.x. [DOI] [PubMed] [Google Scholar]
- Rawlins M. D., Collste P., Bertilsson L., Palmér L. Distribution and elimination kinetics of carbamazepine in man. Eur J Clin Pharmacol. 1975 Feb 28;8(2):91–96. doi: 10.1007/BF00561556. [DOI] [PubMed] [Google Scholar]